• News by Topic

  • News by Topic

  • Relationships news

  • Mind and body

    "Live as if your were to die tomorrow. Learn as if you were to live forever. You must learn to be still in the midst of activity and be vibrantly alive in repose."


This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.


Cholinesterase Inhibitors Found to Increase Risk of Significant Weight Loss in Dementia Patients

Cholinesterase inhibitors, which are commonly used to treat dementia, may increase the risk of adverse weight loss in people 65 and older, reports a new study by researchers at the University of California, San Francisco (UCSF). Because severe weight loss can ultimately result in death, the findings suggest that clinicians should consider this risk when prescribing cholinesterase inhibitors such as donepezil (Aricept), galantamine (Razadyne), and rivastigmine (Exelon).While previous studies have suggested an association between cholinesterase inhibitors like donepezil or galantamine and weight loss, the new analysis provides the first evidence of...


Share |

Published By: Psychiatric News - Monday, 3 August, 2015

Copyright © 2016 Psychology One. All rights reserved. This site is for education & information purposes. This site is not a substitute for professional psychological, medical or psychiatric treatment.